Professional Summary

Professional Overview

Isabella Attinger-Toller is an experienced Chief Technology Officer (CTO) with a strong background in the pharmaceutical and biotechnology industries. She specializes in pharmacology, drug development, and leading technology-driven initiatives that drive innovation and business growth.

Experience Summary

Current Role

As the Chief Technology Officer at Araris Biotech AG, Isabella is responsible for overseeing the company's technological strategy, leading the development of novel therapeutic platforms, and ensuring the efficient and effective implementation of cutting-edge technologies. She plays a pivotal role in shaping the company's research and development efforts, driving the advancement of Araris Biotech's pipeline, and fostering a culture of innovation.

Career Progression

Prior to her current role, Isabella held various leadership positions, including Managing Director at Attinger-Toller Consulting in Vancouver, Canada, and Director of Pharmacology at Covagen, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Throughout her career, she has demonstrated a strong track record of driving strategic initiatives, leading cross-functional teams, and delivering tangible results that have positively impacted the organizations she has been a part of.

Academic Background

Isabella holds a PhD in Tumor Biology from the University of Zurich, where she specialized in advancing our understanding of tumor biology and exploring novel therapeutic approaches.

Areas of Expertise

• Pharmacology and drug development

• Therapeutic platform design and optimization

• Technology strategy and implementation

• Cross-functional team leadership

• Innovative problem-solving and decision-making

• Strategic planning and execution

Professional Impact

During her tenure at Covagen, Isabella played a pivotal role in the development of innovative biotherapeutic candidates, contributing to the advancement of the company's pipeline and positioning it for success. Her leadership and technical expertise have been instrumental in driving technological progress and fostering a culture of continuous improvement.

Conclusion

With her extensive experience, technical expertise, and proven track record of success, Isabella Attinger-Toller is well-positioned to drive Araris Biotech's technological agenda and contribute to the company's growth and industry impact as a Chief Technology Officer.